Primary interstitial lung disease specific to childhood due to alveolar vascular disorder

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

Regulatory Watchboard

1 event
Jun 1996

Albenza: FDA approved

Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder.
Search all trials →
Search clinical trials for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder

Recent News & Research

No recent news articles indexed yet for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder.
Search PubMed for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder

Browse all Primary interstitial lung disease specific to childhood due to alveolar vascular disorder news →

Specialist Network

No specialists currently listed for Primary interstitial lung disease specific to childhood due to alveolar vascular disorder.

View all Primary interstitial lung disease specific to childhood due to alveolar vascular disorder specialists →

Quick Actions